情報利用促進部
研究業績
  1. Aikawa H, Fujino M, Nakao K, Nakai M, Kanaoka K, Sumita Y, Miyamoto Y, Takagi K, Otsuka F, Kataoka Y, Asaumi Y, Tahara Y, Nicholls SJ, Tsujita K, Noguchi T. Diversity in Acute Autoimmune Pericarditis: Nationwide Analysis of In-Hospital Outcomes and Recurrence. JACC: Asia. 4, 721-731, 2024.
  2. Otsuka Y, Ishii M, Ikebe S, Nakamura T, Tsujita K, Matoba T, Kohro T, Oba Y, Kabutoya T, Kario K, Imai Y, Kiyosue A, Mizuno Y, Nochioka K, Nakayama M, Iwai T, Miyamoto Y, Sato H, Akashi N, Fujita H, Nagai R. Changes in systolic blood pressure during hospitalisation and bleeding events after percutaneous coronary intervention. Open Heart. 11, e002987, 2024.
  3. Hitomi Y, Imai Y, Kuwabara M, Oba Y, Kabutoya T, Kario K, Makimoto H, Kohro T, Shiraki E, Akashi N, Fujita H, Matoba T, Miyamoto Y, Kiyosue A, Tsujita K, Nakayama M, Nagai R; CLIDAS research group. Relationship between the number of drugs used during percutaneous coronary intervention and adverse events in patients with chronic coronary syndrome: Analysis of CLIDAS database. IJC Heart & Vasculature. 54, 101507, 2024.
  4. Hisamatsu T, Kadota A, Hayakawa T, Kita Y, Harada A, Okami Y, Kondo K, Ohkubo T, Okamura T, Okayama A, Ueshima H, Miura K; NIPPON DATA80 Research Group (Saitoh S, Sakata K, Hozawa A, Nakamura Y, Nishi N, Ohkubo T, Murakami Y, Ojima T, Tamakoshi K, Nakagawa H, Kita Y, Kadota A, Nakamura Y, Miyamatsu N, Hayakawa T, Okuda N, Yoshita K, Miyamoto Y, Watanabe M, Fujiyoshi A, Kodama K, Kasagi F, Kiyohara Y). High blood pressure and colorectal cancer mortality in a 29-year follow-up of the Japanese general population: NIPPON DATA80. Hypertension Research. 47, 206-214, 2024.
  5. Kanaoka K, Nasu T, Kikuchi A, Ijichi T, Shibata T, Kida K, Kagiyama N, Fujimoto W, Ishii S, Iwanaga Y, Miyamoto Y, Matsumoto S. Risk stratification by renal function and NYHA class in patients with hypotension initiated on sacubitril/valsartan: a retrospective cohort study from 17 centres in Japan. Open Heart. 11, e002764, 2024.
  6. Nochioka K, Nakayama M, Akashi N, Matoba T, Kohro T, Oba Y, Kabutoya T, Imai Y, Kario K, Kiyosue A, Mizuno Y, Iwai T, Miyamoto Y, Ishii M, Nakamura T, Tsujita K, Sato H, Fujita H, Nagai R; CLIDAS research group. Change in pulse pressure and cardiovascular outcomes after percutaneous coronary intervention: The CLIDAS study. IJC Heart & Vasculature. 53, 101430, 2024.
  7. Sawamura A, Kanaoka K, Motokawa T, Katano S, Kono Y, Ohya Y, Miura SI, Fukuma N, Makita S, Miyamoto Y, Izawa H. Relationship Between Participation of In-Hospital Cardiac Rehabilitation and Regional Characteristics in Japan - Insight From the Japanese Registry of All Cardiac and Vascular Diseases and the Diagnosis Procedure Combination. Circulation Reports. 6, 424-429, 2024.
  8. Tonegawa-Kuji R, Nishida T, Sumita Y, Miyamoto Y, Kanaoka K. Current status of wearable cardioverter-defibrillator use in Japan. Journal of Arrhythmia. 40, 998-1000, 2024.
  9. Tonegawa-Kuji R, Yamagata K, Kanaoka K, Wakamiya A, Inoue YY, Miyamoto K, Miyamoto Y, Kiyohara E, Kusano K. Maximum burn prevention practice vs conventional care after direct current cardioversion treatment: The BURN-PREVENTION trial. Heart Rhythm. 21, 2060-2062, 2024.
  10. Nakashima T, Tonegawa-Kuji R, Nakamura K, Kanaoka K, Nakai M, Nagase M, Yamaura M, Ido T, Takahashi S, Aoyama T, Nagashima K, Masuda M, Yamashita S, Miyamoto K, Iwasaki YK, Satomi K, Takatsuki S, Inoue K, Kusano K, Yamane T, Shimizu W. Impact of Being Underweight on the Safety and Efficacy of Atrial Fibrillation Ablation: An Analysis From the Japanese Catheter Ablation Registry. Circulation: Arrhythmia and Electrophysiology. 17, e013026, 2024.
  11. Kusano K, Inoue K, Kanaoka K, Miyamoto K, Okumura Y, Iwasaki YK, Satomi K, Takatsuki S, Nakamura K, Iwanaga Y, Yamane T, Shimizu W; J-AB registry investigators. The Japanese Catheter Ablation Registry (J-AB): Annual report in 2022. Journal of Arrhythmia. 40, 1053-1058, 2024.
  12. Tara S, Yamamoto T, Kanaoka K, Oka E, Shiomura R, Matsuda J, Nakata J, Miyachi H, Onoue K, Saito Y, Shimizu W, Asai K; Japanese Registry of Fulminant Myocarditis Investigators. Effects of Cardioprotective Drugs on 90-Day Mortality or Heart Transplantation in Patients With Fulminant Myocarditis. Circulation Reports. 6, 322-332, 2024.
  13. Miyamoto K, Kanaoka K, Ohta Y, Yoh M, Takahashi H, Tonegawa-Kuji R, Miyazaki Y, Wakamiya A, Ueda N, Nakajima K, Kamakura T, Wada M, Ishibashi K, Inoue-Yamada Y, Nagase S, Aiba T, Ichikawa H, Narai A, Nakase T, Koga M, Fukuda T, Kataoka N, Takagi M, Kusano K. Multicenter Prospective Randomized Study Comparing the Incidence of Periprocedural Cerebral Embolisms Caused by Catheter Ablation of Atrial Fibrillation Between Cryoballoon and Radiofrequency Ablation (Embo-Abl Study). Circulation: Arrhythmia and Electrophysiology. 17, e012952, 2024.
  14. Matsumoto S, McMurray JJV, Nasu T, Ishii S, Kagiyama N, Kida K, Fujimoto W, Kikuchi A, Ijichi T, Shibata T, Ikeda T, Kanaoka K. Relevant adverse events and drug discontinuation of sacubitril/valsartan in a real-world Japanese cohort: REVIEW-HF registry. Journal of Cardiology. 84, 133-140, 2024.
  15. 渡邉 至. 糖尿病と飲酒習慣. 調剤と情報. 30, 1817-1820, 2024.
  16. 中村 好一, 渡邉 至　. 傷病統計. 社会・環境と健康2024-2025. 80-84, 2024.